TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 11.95%73.59B | 1.46%133.62B | -4.37%65.73B | 15.03%131.7B | 30.98%68.74B | 32.91%114.49B | 31.40%52.48B | 2.33%86.14B | -3.60%39.94B | -6.67%84.18B |
Operating income | 11.95%73.59B | 1.46%133.62B | -4.37%65.73B | 15.03%131.7B | 30.98%68.74B | 32.91%114.49B | 31.40%52.48B | 2.33%86.14B | -3.60%39.94B | -6.67%84.18B |
Cost of sales | 6.77%-55.79B | 0.70%-112.67B | -11.26%-59.84B | -35.01%-113.46B | -46.37%-53.78B | -25.83%-84.04B | -9.78%-36.74B | 1.37%-66.79B | 0.94%-33.47B | 9.47%-67.72B |
Operating expenses | 6.77%-55.79B | 0.70%-112.67B | -11.26%-59.84B | -35.01%-113.46B | -46.37%-53.78B | -25.83%-84.04B | -9.78%-36.74B | 1.37%-66.79B | 0.94%-33.47B | 9.47%-67.72B |
Gross profit | 202.12%17.8B | 14.89%20.95B | -60.60%5.89B | -40.11%18.24B | -4.96%14.96B | 57.34%30.45B | 143.27%15.74B | 17.56%19.36B | -15.36%6.47B | 6.91%16.46B |
Selling expenses | -20.50%-366.5M | -26.37%-755.27M | -0.74%-304.14M | -13.69%-597.68M | -15.94%-301.89M | -31.46%-525.71M | -70.68%-260.38M | 10.94%-399.89M | 47.69%-152.56M | -20.97%-449.04M |
Administrative expenses | 12.61%-2.45B | 16.53%-4.95B | 8.24%-2.81B | -3.95%-5.93B | -19.93%-3.06B | -40.87%-5.71B | -37.30%-2.55B | -11.15%-4.05B | -19.43%-1.86B | 5.73%-3.65B |
Revaluation surplus | -11,319.18%-1.61B | 73.49%-49.04M | 104.15%14.39M | -58.37%-184.98M | 70.24%-346.84M | 59.90%-116.81M | -1,452.65%-1.17B | -310.94%-291.26M | 446.10%86.17M | -65.28%138.08M |
-Changes in the fair value of other assets | -11,319.18%-1.61B | 73.49%-49.04M | 104.15%14.39M | -58.37%-184.98M | 70.24%-346.84M | 59.90%-116.81M | -1,452.65%-1.17B | -310.94%-291.26M | --86.17M | -65.28%138.08M |
Operating interest expense | ---- | ---- | ---- | ---- | 12.58%-1.65B | 19.53%-3.63B | 14.54%-1.89B | 13.67%-4.51B | 24.37%-2.21B | -17.73%-5.22B |
Special items of operating profit | -20.90%1.24B | -23.12%2.77B | 11.35%1.57B | 78.55%3.6B | 0.54%1.41B | -3.26%2.02B | 96.56%1.4B | 114.04%2.08B | 8.19%713.15M | -31.84%973.72M |
Operating profit | 234.75%14.61B | 18.80%17.97B | -60.34%4.36B | -32.77%15.12B | -2.37%11B | 84.52%22.49B | 270.03%11.27B | 47.55%12.19B | -13.11%3.05B | -3.43%8.26B |
Financing cost | -5.86%-1.56B | -8.23%-3.27B | ---1.47B | ---3.02B | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | -13.67%823.95M | 137.07%1.19B | 320.73%954.43M | 718.18%503.34M | 1,848.71%226.85M | -88.04%61.52M | -96.71%11.64M | 1.03%514.59M | -6.00%354.28M | 18.58%509.35M |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---5.41M | ---- | ---- | ---- |
Earning before tax | 260.88%13.87B | 26.05%15.89B | -65.77%3.84B | -44.10%12.61B | -0.41%11.23B | 77.53%22.55B | 231.66%11.28B | 44.84%12.7B | -12.42%3.4B | 5.22%8.77B |
Tax | -343.18%-3.86B | -21.27%-3.39B | 65.75%-871.67M | 50.96%-2.8B | 10.78%-2.55B | -152.48%-5.71B | -379.01%-2.85B | 2.43%-2.26B | 45.84%-595.59M | 9.16%-2.32B |
After-tax profit from continuing operations | 236.74%10.01B | 27.41%12.5B | -65.78%2.97B | -41.78%9.81B | 3.11%8.69B | 61.31%16.85B | 200.37%8.42B | 61.81%10.44B | 0.78%2.8B | 11.56%6.46B |
Earning after tax | 236.74%10.01B | 27.41%12.5B | -65.78%2.97B | -41.78%9.81B | 3.11%8.69B | 61.31%16.85B | 200.37%8.42B | 61.81%10.44B | 0.78%2.8B | 11.56%6.46B |
Minority profit | 65.50%852.97M | -6.32%1.04B | -38.57%515.4M | 42.76%1.11B | 198.36%838.99M | 1,615.01%775.46M | 1,127.36%281.2M | -114.23%-51.19M | -108.95%-27.37M | -5.02%359.81M |
Profit attributable to shareholders | 272.66%9.15B | 31.70%11.46B | -68.69%2.46B | -45.86%8.7B | -3.64%7.85B | 53.14%16.07B | 187.53%8.14B | 72.20%10.5B | 14.32%2.83B | 12.72%6.1B |
Basic earnings per share | 272.97%0.966 | 29.25%1.2095 | -69.53%0.259 | -47.19%0.9358 | -5.87%0.85 | 45.13%1.772 | 173.64%0.903 | 72.29%1.221 | 14.98%0.33 | 13.98%0.7087 |
Diluted earnings per share | 272.97%0.966 | 27.72%1.1952 | -69.53%0.259 | -45.34%0.9358 | -5.87%0.85 | 40.20%1.7119 | 177.85%0.903 | 74.95%1.221 | 13.24%0.325 | 17.57%0.6979 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.